CUCCURULLO, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 1.436
EU - Europa 976
AS - Asia 99
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
SA - Sud America 1
Totale 2.518
Nazione #
US - Stati Uniti d'America 1.431
IE - Irlanda 431
UA - Ucraina 124
FI - Finlandia 99
IT - Italia 89
DE - Germania 82
SE - Svezia 76
CN - Cina 63
GB - Regno Unito 63
IN - India 10
VN - Vietnam 10
IR - Iran 7
CA - Canada 5
NL - Olanda 5
SG - Singapore 4
BE - Belgio 3
EU - Europa 3
RU - Federazione Russa 3
GE - Georgia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
KR - Corea 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TR - Turchia 1
Totale 2.518
Città #
Dublin 431
Jacksonville 321
Chandler 292
Wilmington 120
Houston 90
San Mateo 73
Helsinki 59
Beijing 43
Princeton 40
Ann Arbor 38
Rome 36
Boardman 33
Woodbridge 27
Falls Church 16
Los Angeles 13
Molise 13
Mountain View 12
Dong Ket 10
Leawood 10
Norwalk 7
Auburn Hills 6
New York 6
Ardabil 5
Guiyang 5
Jinan 5
Milan 5
Ashburn 4
Augusta 4
Cambridge 4
Monmouth Junction 4
Chieti 3
Huizen 3
Mumbai 3
Redwood City 3
Toronto 3
Ansbach 2
Bangalore 2
Brussels 2
Fairfield 2
Phoenix 2
Rockville 2
Santa Clara 2
Shenyang 2
Taiyuan 2
Taizhou 2
Tbilisi 2
Auckland 1
Aurora 1
Berlin 1
Borås 1
Boston 1
Changsha 1
Charlotte 1
Chennai 1
Evanston 1
Falkenstein 1
Fortaleza 1
Geislingen an der Steige 1
Hangzhou 1
Istanbul 1
Lvov 1
Nanjing 1
Odesa 1
Opava 1
Orlando 1
Quezon 1
Saint Louis 1
Stockholm 1
Sydney 1
Tehran 1
Vancouver 1
Ville-sur-haine 1
Würzburg 1
Zhengzhou 1
Totale 1.797
Nome #
IL-32: a newly-discovered proinflammatory cytokine 80
IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg Cells. 80
Impact of RANTES, MCP-1 and IL-8 in mast cells 78
Inhibitory activity of salicylic acid on lipoxygenase-dependent lipid peroxidation 76
COX-2 and the vasculature: angel or evil? 75
Impact of IL-32 on histamine release by human derived umbilical cord blood mast cells 74
COX-2 expression in atherosclerosis: the good, the bad or the ugly? 74
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty 73
Soluble forms of RAGE in internal medicine. 73
Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control 72
Determinants of platelet activation in hypertensives with microalbuminuria. 72
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 71
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 70
Association between 5-lipoxygenase expression and plaque instability in humans. 69
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost 69
Endogenous secretory RAGE in obese women: Association with platelet activation and oxidative stress 67
Diabetes mellitus and thrombosis.. 66
Serum albumin and biomolecular oxidative damage of human atherosclerotic plaques 66
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 65
Autism and Immunity: Revisited Study 64
4 Ascorbic acid supplementation reduces oxidative stress and platelet biochemical function in type 2 diabetic patients. Relevance of ascorbic acid dosage and formulation. 64
Platelet Function in Health and Disease: from Molecular Mechanisms, Redox Considerations to Novel Therapeutic Opportunities 64
Vitamins and mast cells. 61
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 59
Myocardial glutathione metabolic status in fat-fed rabbits 58
The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activator. 58
Cardiovascular risk and dietary sugar intake: Is the link so sweet? 58
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 57
Infections and mast cells 56
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control 55
Bicarbonate-dependent, carbonate radical anion-driven tocopherol-mediated human LDL peroxidation: An in vitro and in vivo study 54
Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells 52
Cardiac Events in Hypertensive Patients With Renal Artery Stenosis Treated With Renal Angioplasty or Drug Therapy: Meta-Analysis of Randomized Trials 52
Prediction of carotid plaques in hypertensive patients by risk factors, left ventricular hypertrophy, and epicardial adipose tissue thickness. 51
Mast cells and arachidonic acid cascade in inflammation 51
Inflammatory compounds: Neuropeptide substance P and cytokines 51
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 50
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 48
Mean platelet volume variation after biologic therapy in psoriasis and psoriatic arthritis 46
Inter-relationship between chemokines and mast cells 44
Totale 2.523
Categoria #
all - tutte 11.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.061


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 0 1 5
2019/2020264 2 3 45 2 40 5 40 1 60 12 9 45
2020/2021360 8 40 1 53 45 13 41 0 42 2 92 23
2021/2022217 16 62 7 8 17 25 3 27 27 9 8 8
2022/20231.089 111 55 16 112 56 96 3 47 536 28 10 19
2023/2024125 58 14 13 4 7 9 0 5 2 13 0 0
Totale 2.523